Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

CTMX FY 2013 Earnings — CytomX Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CTMXCytomX Therapeutics, Inc.

$809M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$888,000

Gross Profit

$888,000100.0% margin

Operating Income

-$15M-1684.2% margin

Net Income

-$15M-1705.3% margin

EPS (Diluted)

$-15.32

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$343,000

Balance Sheet

Total Assets

$14M

Total Liabilities

$58M

Stockholders' Equity

-$44M

Cash & Equivalents

$9M

← FY 2014 All Quarters